Analysis
What would make continuous fermentation a better business?
ECOFERM sets a research direction. A commercial comparison still needs campaign reliability, recovery, quality and a clear cost boundary.
Useful for: InvestorsFood biotech
Brief
Continuous fermentation: which evidence should precede the next commitment?
Turn a process announcement into a diligence request covering campaign stability, accepted output, cost boundaries and qualification.
Useful for: Investors
Opinion
Why investors pass on food biotech companies
A polite rejection is not a diagnosis. Seven questions to test against the evidence from your last fundraising conversations.
Useful for: Investors
Opinion
Why food biotech platforms should start with an ingredient
Platforms are earned through repeatable commercial capability. A defined first ingredient makes that work concrete.
Useful for: R&D & Innovation